Trials / Unknown
UnknownNCT04892407
Algeness DF 3.5% Compared to Voluma in Volume Deficit in Mid-face
A Prospective, Multi-center, Randomized, Controlled, Single-blind Study of the Safety and Effectiveness of Algeness® DF 3.5% Deep Volumizing Filler to Correct Age-related Volume Deficit in the Mid-face
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 308 (estimated)
- Sponsor
- Advanced Aesthetic Technologies, Inc · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Accepted
Summary
A prospective, randomized, controlled study of Algeness® DF 3.5% Deep Volumizing Filler comparing to Juvéderm Voluma to correct midface volume loss.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Algeness® DF 3.5% | dermal filler CE Mark approved for treatment of cheek and midface volume loss |
| DEVICE | Juvéderm Voluma | dermal filler CE Mark approved for treatment of cheek and midface volume loss |
Timeline
- Start date
- 2021-09-06
- Primary completion
- 2022-12-01
- Completion
- 2024-08-01
- First posted
- 2021-05-19
- Last updated
- 2022-06-27
Locations
9 sites across 7 countries: Belgium, France, Germany, Israel, Malaysia, Spain, United Arab Emirates
Source: ClinicalTrials.gov record NCT04892407. Inclusion in this directory is not an endorsement.